Thursday, October 14, 2021

Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer

xlomafota13 shared this article with you from Inoreader

jamanetwork.com

This systematic review and meta-analysis assesses the efficacy and safety of neoadjuvant immunotherapy for resectable head and neck squamous cell carcinoma.
View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...